They are and known to play a crucial role in immune system development and have been shown to impact the early development and future health of children. Using upcycled byproducts from the cheese making process, EXOSOMM has created a technology to produce these exosomes for potential use in supporting adults with inflammatory disorders.

The technology is inspired by the unique health properties of mother's milk and aims to provide exosomes as a nutrient to manage chronic metabolic inflammatory disorders and enhance overall well-being. Initial research is focused on exploring the role of exosomes in managing conditions such as Crohn's and Colitis.

Preclinical studies have shown promising results, demonstrating the potential of exosomes to reduce inflammation in inflammatory bowel diseases (IBD), improve glucose tolerance, and prevent organ damage. The company aims to provide natural relief and improve the quality of life for millions of IBD patients, as well as individuals with diabetes and other metabolic disorders.

The primary focus is on catering to medical food brands and creating food formulas specifically designed for individuals with special dietary requirements. Additionally, the exosomes can be utilized as a functional ingredient in a wide range of food and beverage products.